Evelo Biosciences, Inc. (EVLO)

USD 0.0

(0.0%)

Net Debt Summary of Evelo Biosciences, Inc.

  • Evelo Biosciences, Inc.'s latest annual net debt in 2022 was 3.19 Million USD , up 126.33% from previous year.
  • Evelo Biosciences, Inc.'s latest quarterly net debt in 2023 Q3 was 16.68 Million USD , down -61.07% from previous quarter.
  • Evelo Biosciences, Inc. reported annual net debt of -12.14 Million USD in 2021, up 57.85% from previous year.
  • Evelo Biosciences, Inc. reported annual net debt of -28.82 Million USD in 2020, up 50.48% from previous year.
  • Evelo Biosciences, Inc. reported quarterly net debt of 23.22 Million USD for 2023 Q1, up 626.2% from previous quarter.
  • Evelo Biosciences, Inc. reported quarterly net debt of 16.68 Million USD for 2023 Q3, down -61.07% from previous quarter.

Annual Net Debt Chart of Evelo Biosciences, Inc. (2022 - 2016)

Historical Annual Net Debt of Evelo Biosciences, Inc. (2022 - 2016)

Year Net Debt Net Debt Growth
2022 3.19 Million USD 126.33%
2021 -12.14 Million USD 57.85%
2020 -28.82 Million USD 50.48%
2019 -58.19 Million USD 57.08%
2018 -135.61 Million USD -379.54%
2017 -28.28 Million USD -404.55%
2016 -5.6 Million USD 0.0%

Peer Net Debt Comparison of Evelo Biosciences, Inc.

Name Net Debt Net Debt Difference
America Great Health 1.81 Million USD -76.089%
Ampio Pharmaceuticals, Inc. -3.81 Million USD 183.827%
Aridis Pharmaceuticals, Inc. 1.25 Million USD -155.024%
Biora Therapeutics, Inc. 32.21 Million USD 90.073%
Bio-Path Holdings, Inc. -939 Thousand USD 440.575%
Better Therapeutics, Inc. -860 Thousand USD 471.86%
Calithera Biosciences, Inc. -23.78 Million USD 113.445%
Comera Life Sciences Holdings, Inc. 328.44 Thousand USD -873.691%
Gene Biotherapeutics, Inc. - USD -Infinity%
eFFECTOR Therapeutics, Inc. 4.57 Million USD 30.022%
Eloxx Pharmaceuticals, Inc. -5.82 Million USD 154.92%
Evolutionary Genomics, Inc. 3.16 Million USD -0.989%
Finch Therapeutics Group, Inc. 5 Million USD 36.066%
Galera Therapeutics, Inc. 134.04 Million USD 97.614%
Innovation1 Biotech Inc. 179.15 Thousand USD -1685.096%
Kiromic BioPharma, Inc. 12.33 Million USD 74.081%
Molecular Templates, Inc. 707 Thousand USD -352.334%
Navidea Biopharmaceuticals, Inc. 438.44 Thousand USD -629.398%
NexImmune, Inc. -3.13 Million USD 202.054%
Orgenesis Inc. 21.78 Million USD 85.32%
Panbela Therapeutics, Inc. 2.61 Million USD -22.248%
Point of Care Nano-Technology, Inc. -498.00 USD 642268.675%
PaxMedica, Inc. Common Stock -4.71 Million USD 167.889%
Scopus BioPharma Inc. -124.57 Thousand USD 2667.128%
Sorrento Therapeutics, Inc. 110.87 Million USD 97.116%
Statera Biopharma, Inc. 14.41 Million USD 77.817%
TRACON Pharmaceuticals, Inc. -7.59 Million USD 142.101%
Trevena, Inc. 2.25 Million USD -41.63%
Vaxxinity, Inc. 10.13 Million USD 68.437%
Vaccinex, Inc. -1.28 Million USD 348.292%
Vicapsys Life Sciences, Inc. 344.44 Thousand USD -828.447%
Viracta Therapeutics, Inc. 13.23 Million USD 75.844%
ZIVO Bioscience, Inc. 71.96 Thousand USD -4344.012%